Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
April 4th, 2025 |
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed) |
National Institutes of Health |
February 28th, 2023 |
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) |
National Institutes of Health |
November 21st, 2022 |
Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed) |
National Institutes of Health |
August 8th, 2025 |
Agency for Healthcare Research and Quality (AHRQ)-sponsored National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) |
Agency for Health Care Research and Quality |
January 30th, 2025 |
Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2025 |
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) |
National Institutes of Health |
September 7th, 2025 |
Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) |
National Institutes of Health |
October 24th, 2022 |
HIV Care and Treatment |
Guatemala USAID Guatemala City |
May 7th, 2025 |
NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R01 Clinical Trial Optional) |
National Institutes of Health |
May 25th, 2025 |
Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed) |
National Institutes of Health |
November 8th, 2022 |
Support for 988 Tribal Response Cooperative Agreements |
Substance Abuse and Mental Health Services Adminis |
May 7th, 2025 |
NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional) |
National Institutes of Health |
December 6th, 2022 |
Pediatric Clinical Pharmacology Research Career Development Award (K12 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2025 |
Development of Animal Models and Related Materials for HIV/AIDS Research (R24 Clinical Trials Not Allowed) |
National Institutes of Health |
March 17th, 2023 |
Increasing PrEP Use Among Disproportionately Affected Populations in the United States |
Centers for Disease Control and Prevention ERA |
November 29th, 2022 |
NIH Blueprint for Neuroscience Research: Computational Training in Neuroscience and Behavior (T90/R90 - Clinical Trial Not Allowed) |
National Institutes of Health |
September 7th, 2025 |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
February 23rd, 2023 |
Identifying and Addressing Historical and Structural Drivers of Medical Mistrust among Hispanic/Latino Gay, Bisexual and Other Men Who Have Sex with Men (HLMSM) for HIV Prevention |
Centers for Disease Control and Prevention ERA |
January 6th, 2023 |
Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations |
Centers for Disease Control and Prevention ERA |
January 6th, 2023 |
Developing a Public Health Tool to Predict the Virality of Vaccine Misinformation Narratives |
Centers for Disease Control and Prevention ERA |
|
February 2nd, 2023 |
Approach to Adult Vaccine Counseling |
Centers for Disease Control and Prevention ERA |
January 17th, 2023 |
Developing, Implementing, and Evaluating Protocols to Increase Routine Adult Immunization Coverage Among Persons Who are Incarcerated |
Centers for Disease Control and Prevention ERA |
January 13th, 2023 |
Programmatic Interventions to Increase Uptake of Influenza and COVID-19 Vaccination Among Students Attending Institutions of Higher Education |
Centers for Disease Control and Prevention ERA |
February 16th, 2023 |
Research Grants to Rigorously Evaluate Innovative and Promising Strategies to Prevent Firearm-Related Violence and Injuries (R01) |
Centers for Disease Control and Prevention ERA |
February 16th, 2023 |
Research Grants to Inform Firearm-Related Violence and Injury Prevention Strategies (R01) |
Centers for Disease Control and Prevention ERA |
March 22nd, 2023 |
Expanding Rapid Initiation of Antiretroviral Therapy in Non-traditional Settings: Emergency Department |
Centers for Disease Control and Prevention ERA |
November 18th, 2022 |
Multi-Omics for Health and Disease - 'Omics Production Centers (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
November 15th, 2022 |
Primary Care Training and Enhancement - Residency Training in Mental and Behavioral Health (PCTE-RTMB) |
Health Resources and Services Administration |
September 7th, 2025 |
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) |
National Institutes of Health |
February 27th, 2023 |
Long-Acting Injectables for the Treatment of HIV in Non-Clinic Community-Based Settings |
Centers for Disease Control and Prevention ERA |
November 18th, 2022 |
Multi-Omics for Health and Disease - Data Analysis and Coordination Center (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
November 18th, 2022 |
Multi-Omics for Health and Disease - Disease Study Sites (U01 Clinical Trial Optional) |
National Institutes of Health |
November 30th, 2022 |
Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier (UC2 Clinical Trial Not Allowed) |
National Institutes of Health |
March 17th, 2023 |
Exploring Preferences for Long-Acting Antiretroviral Therapies (LA-ART) in a Community-Based Sample of Priority Populations Living with HIV Who are Disproportionately Affected |
Centers for Disease Control and Prevention ERA |
September 1st, 2025 |
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) |
National Institutes of Health |
December 23rd, 2022 |
Understanding the Supply of Professional Dementia Care Providers and Their Decisions (U54 Clinical Trial Not Allowed) |
National Institutes of Health |
October 26th, 2023 |
Clinical, Behavioral, and Physiological Studies of Open- and Closed-loop Platforms: Toward Personalized, Fully Automated, Accessible Systems (R01 Clinical Trial Required) |
National Institutes of Health |
November 1st, 2022 |
Centers for Oceans and Human Health 4: Impacts of Climate Change on Oceans and Great Lakes (COHH4) (P01 Clinal Trial Optional) |
National Institutes of Health |
February 6th, 2024 |
NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional) |
National Institutes of Health |
October 17th, 2022 |
Resiliency in Communities After Stress and Trauma |
Substance Abuse and Mental Health Services Adminis |